From: [Sales rep name redacted]
Sent: Wednesday, December 06, 2006 11:22 AM
To: [Doctor name redacted]
Subject: Miraviroc meeting
Hi [Doctor name redacted],
Do you have a few minutes in the afternoon tomorrow to meet with Dennis Pontani/Miraviroc Medical Director?
[Sales rep name redacted]
--------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------
In conclusion, there appears to be overwhelming written evidence that Pfizer systematically used the HIV sales force to premarket maraviroc, before FDA approval, to "research naïve doctors."
Meanwhile, I'm told by sources inside Pfizer that an internal legal investigation of this matter has just started and an external law firm is interrogating Pfizer sales representatives.
Not that Pfizer had much choice after all the information I've made public on this matter . . .
The Pfizer sales rep who gave me this concludes with the following comment: "I hope you see the amount of work I did on behalf of Maraviroc . . . all unsolicited."
And that is exactly the problem. Sales reps can't talk about unapproved indications or unapproved drugs unless the doctors ask them first . . . if they do, it is called OFF-LABEL MARKETING.
Sent: Wednesday, December 06, 2006 11:22 AM
To: [Doctor name redacted]
Subject: Miraviroc meeting
Hi [Doctor name redacted],
Do you have a few minutes in the afternoon tomorrow to meet with Dennis Pontani/Miraviroc Medical Director?
[Sales rep name redacted]
--------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------
In conclusion, there appears to be overwhelming written evidence that Pfizer systematically used the HIV sales force to premarket maraviroc, before FDA approval, to "research naïve doctors."
Meanwhile, I'm told by sources inside Pfizer that an internal legal investigation of this matter has just started and an external law firm is interrogating Pfizer sales representatives.
Not that Pfizer had much choice after all the information I've made public on this matter . . .
The Pfizer sales rep who gave me this concludes with the following comment: "I hope you see the amount of work I did on behalf of Maraviroc . . . all unsolicited."
And that is exactly the problem. Sales reps can't talk about unapproved indications or unapproved drugs unless the doctors ask them first . . . if they do, it is called OFF-LABEL MARKETING.
Next Page 1 | 2 | 3 | 4 | 5 | 6 | 7
(Note: You can view every article as one long page if you sign up as an Advocate Member, or higher).
